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The prevalence of infection with Bartonella henselae was investigated in cats from different areas of Switzer-
land. Serum samples of 728 cats were examined for antibodies to B. henselae by immunofluorescent antibody
testing, and the results were analyzed with a view to a possible correlation between a positive titer and
signalment, clinical signs, infection with feline leukemia virus (FeLV), feline immunodeficiency virus (FIV),
feline coronavirus (FCoV), or feline spumavirus (FeSFV), and the living environments of the cats. The
seroprevalence in all cats was 8.3%. No significantly different prevalence was found in sick versus healthy cats
(9.2 versus 7.2%); however, in sick cats seropositive for B. henselae, there was an increased frequency of
stomatitis and a variety of diseases of the kidneys and the urinary tract. There was an increased prevalence of
B. henselae in cats positive for FCoV (P 5 0.0185) or FeSFV (P 5 0.0235) and no statistically significant
increased prevalence in cats infected with FeLV or FIV. There was no correlation between a positive titer and
sex or breed. The same prevalence of B. henselae antibodies was found in cats with and without access to the
outdoors and in cats from single- and multicat households. The seroprevalence was increased in cats living
south of the Alps (12.1%); however, this difference was not significant (P 5 0.0616).
Bartonella henselae has been demonstrated to be a causative
agent of cat scratch disease (6, 21, 27), bacillary angiomatosis
(13), endocarditis (8), bacteremia, and hepatic peliosis (26) in
humans. Cat bite or scratch is strongly associated with cat
scratch disease (27) and bacillary angiomatosis (24). Bartonel-
losis has been diagnosed worldwide; however, its prevalence,
and therefore its impact, differs among geographic regions. In
warm, humid areas, the seroprevalence in cats has been shown
to be much higher than in cold areas, and an association with
the presence of fleas has been made (11).
However, few data are available concerning the clinical im-
portance of B. henselae for cats, and no data are available
concerning the prevalence of B. henselae in cats in Switzerland.
The aim of this study was to investigate whether seropositivity
was associated with the occurrence of viral infections, with
clinical disease, or with the signalment and living conditions of
the cats, and to document the prevalence of B. henselae in cats
in different parts of Switzerland and southern Germany on the
basis of serological examination.
MATERIALS AND METHODS
Between 1987 and 1990, serum samples from 728 cats (304 healthy, 424 sick)
were collected from veterinary practices in different regions in Switzerland and
southern Germany. Information with respect to signalment, disease history,
abnormal clinical findings, and environment was gained from the participating
veterinarians by use of a questionnaire. Serum samples were evaluated for the
presence of antibodies to B. henselae, feline immunodeficiency virus (FIV), feline
coronavirus (FCoV), feline spumavirus (FeSFV), and feline leukemia virus
(FeLV) antigen. Antibodies to B. henselae were detected by an immunofluores-
cence antibody test (IFA) using a technique described previously (21). Briefly,
Vero cells grown in RPMI 1640 medium supplemented with fetal bovine serum
were infected with B. henselae. Infected cells were adjusted to 50,000/ml, and
50-ml aliquots were spotted onto glass slides, air dried, and fixed in acetone.
Positive- and negative-control sera were used in a dilution of 1:50 with every
slide. Cat serum samples were incubated at different dilutions at 37°C for 1 h,
followed by a washing step and incubation with a goat anti-cat immunoglobulin
G conjugated to fluorescein isothiocyanate (Jackson ImmunoResearch Labora-
tories, Inc.; distributed by Milan AG, La Roche, Switzerland). The IFA reaction
was considered positive if specific fluorescence was noted at a titer of $64.
Serum samples showing fluorescence at a 1:64 dilution were titrated by twofold
dilutions up to 1:8,192.
FeLV p27 antigen was demonstrated by a double-antibody sandwich enzyme-
linked immunosorbent assay (ELISA) as described previously (18). Antibodies to
FCoV and FeSFV were measured by IFA as described previously (14, 16).
Antibodies to FIV were detected by ELISA. Positive results were confirmed by
the Western blot technique (15). Serum samples were kept frozen at 270°C until
assayed. Data from B. henselae serology were examined with respect to health
status, prevalence of diseased organ systems, breed, age, sex, living environment
(indoors versus outdoors; single- versus multicat household), and coinfection
with FeLV, FCoV, FIV, or FeSFV. Frequencies were compared by Fisher’s exact
test. Differences were considered significant if P was ,0.05.
RESULTS
Exact data concerning FIV, FCoV, and FeLV are compiled
elsewhere (17). The overall prevalence of antibodies to B.
henselae was found to be 8.3% (61 of 728 samples analyzed).
No significant difference was found in seroprevalence between
healthy and sick animals. Of 304 healthy cats tested, 22 were
seropositive (7.2%). Their median titer was 128 (range, 64 to
8,192). Of 424 sick cats tested, 39 were seropositive (9.2%).
Their median titer was 128 (range, 64 to 2,048). On the basis of
the questionnaires, about 30 parameters were evaluated for
each cat and compared with respect to B. henselae serostatus.
Upon physical examination, two abnormalities were found at
an increased frequency in sick cats seropositive for B. henselae:
stomatitis (P 5 0.0117) and various diseases of the kidneys and
urinary tract that were not further differentiated (P 5 0.0337).
Cats seropositive for B. henselae were more often seroposi-
tive for FCoV (26 of 61 B. henselae-seropositive cats versus 186
of 667 B. henselae-seronegative cats; P 5 0.0185) and FeSFV
(P 5 0.00235) (data not shown). Sick cats seropositive for B.
henselae were more often infected with FIV; however, this
difference was not significant (P 5 0.0616). The prevalence of
seropositive cats was not influenced by infection with FeLV
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(Table 1). There was no correlation between privately owned
cats versus cats brought to an animal shelter, indoor versus
outdoor cats, single- versus multicat households, sex, or breed
and a titer positive for B. henselae. In cats up to the age of 7
years, there was no correlation between age and a positive
titer; however, above the age of 7 years, more cats were sero-
positive (17 of 110; P 5 0.0077) (Fig. 1), and sick cats more
often were seropositive (17 of 93; P 5 0.00235). In fact, all the
seropositive cats in this age group were sick.
There was a difference in prevalence with respect to the
geographic region. Cats living south of the Alps (Tessin) had a
higher prevalence (12.1%; 16 of 132) than animals inhabiting
the northern parts of Switzerland and Germany; however, this
difference was not significant (P 5 0.0616).
DISCUSSION
The data presented here indicate that cats in Switzerland are
fairly commonly infected with B. henselae. This prevalence of
8.3% is markedly lower than those found in other studies of
cats in other countries (1, 2, 4). Climatic differences among
these countries are one possible explanation for this difference.
Jameson et al. (11) have shown that the prevalence of positive
titers is affected by climatic warmth and annual precipitation.
Switzerland is climatically comparable to the northern United
States and Canada, where the prevalence is low (11). We also
have recognized a higher prevalence south of the Alps, al-
though this difference was not significant. A higher prevalence
in the south can be explained by the fact that average temper-
atures south of the Alps are considerably higher. The average
temperature north of the Alps is 3.5°C lower (23). Increased
average temperatures lead to longer survival of fleas, which in
turn can explain a higher infectious pressure on cats by B.
henselae.
Another explanation for the low prevalence observed in this
study may be an underestimation of the true prevalence of the
infection. Underestimation may be expected if the bacteremic
phase, which may last for months, is not paralleled by serocon-
version. If this was the case, some of the acutely bacteremic
cats would have been considered negative. However, in the
study by Koehler et al. (12), there was a close relationship
between bacteremic and seropositive cats, and it has been
found experimentally that seroconversion follows shortly after,
and lasts longer than, bacteremia (22). Therefore, it is likely
that our study did not greatly underestimate the prevalence.
It is recognized that cats infected with B. henselae may be
clinically normal. Although in our study seropositive cats were
not sick more often than seronegative cats, an increased prev-
alence of stomatitis and various urinary tract abnormalities was
found in seropositive cats. Seropositive cats also had a higher
incidence of a positive titer for FeSFV and FCoV. An in-
creased incidence of stomatitis in FeSFV-positive cats (14) and
of renal abnormalities in FIV-positive cats (10) has been rec-
ognized. Hence, the increased prevalence of these clinical ab-
normalities in cats infected with B. henselae in our study may
be associated with B. henselae infection, with one of the viral
infections, or with a combination of these.
Several explanations for an increased prevalence of FCoV
and FeSFV antibodies in B. henselae-positive cats are possible.
First, there may be a problem in the methodology of the tests,
e.g., cross-reactions in the IFA. This explanation is unlikely,
because there were many cats seropositive for only one of the
three diseases. Second, the correlation may be due to simulta-
neous transmission of these diseases. FCoV is most efficiently
transmitted among cats living in close contact through the
oropharyngeal route (20). FeSFV is transmitted through cat
bites (19). Although B. henselae may be transmitted by bites or
scratches, the main route of transmission appears to be
through fleas (3, 5). Consequently, although transmission of
these organisms does not occur by exactly the same means,
transmission requires more or less close social contact. Alter-
natively, by immunosuppression one of these infections may
FIG. 1. Age distribution (frequency of a particular age in percentages) of B.
henselae-positive and -negative cats. The ages of 48 cats were unknown. Numbers
in the bars are the numbers of animals per group. Cats that were $7 years old
were significantly more frequently B. henselae positive (p, P 5 0.0077).
TABLE 1. Seroprevalence of B. henselae in healthy cats in relation to feline viral infections
Virus and titer
No. (%) of healthy cats (n 5 304) No. (%) of sick cats (n 5 424)
B. henselae positive
(n 5 22)
B. henselae negative
(n 5 282)
B. henselae positive
(n 5 39)
B. henselae negative
(n 5 385)
FCoV
,1:25 15 (68.2) 226 (80.1) 20 (51.3) 255 (66.2)
1:25 4 (18.2) 28 (9.9) 10 (25.6) 66 (17.1)
1:100 2 (9.1) 21 (7.4) 7 (17.9) 36 (9.3)
1:400 1 (4.5) 7 (2.5) 2 (5.1) 19 (4.9)
1:1,600 0 0 0 9 (2.3)
$1:25 7 (31.8) 56 (19.9) 19 (48.7) 130 (33.8)
FIV positivea 0 4 (1.4) 3 (7.7) 9 (2.3)
FeLV p27 positive 1 (4.5) 2 (0.7) 2 (5.1) 46 (11.9)
FeSFV positiveb 12/20 (60.0) 92/274 (33.6) 20/35 (57.1) 176/362 (48.6)
a By ELISA and Western blot.
b By IFA; cutoff, $1:40.
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predispose to infection with, or delay clearing of, another or-
ganism. However, there was no significant correlation between
viral diseases known to cause immunosuppression (FeLV and
FIV) and B. henselae infection in the present study. Finally, a
statistical correlation between diseases does not necessarily
reflect a cause-and-effect relationship.
In contrast with the findings of Ueno et al. (25), clinical signs
of cats seropositive for FIV and B. henselae did not differ from
those of cats infected with FIV alone. This finding and the fact
that the increased prevalence of FIV-positive cats was not
significant may be associated with the low prevalence of FIV-
positive cats in our population (2.2%).
Whereas, in contrast with the findings of other studies, no
increased seroprevalence of B. henselae was seen in young cats,
a statistical correlation with old age ($7 years) was found.
Assuming that, at least in some animals, seroreversion follows
clearance of the infection (7), an explanation for this finding is
that very old cats may be less immunocompetent and thus
unable to clear the infection. Many of these cats were between
7 and 9 years old, making age-related immunosuppression an
unlikely cause. On the other hand, all the seropositive cats in
this age group were sick. Two explanations for this finding are
possible: either B. henselae infection makes cats vulnerable to
other diseases, or a diseased cat is less able to clear the infec-
tion with B. henselae.
It is expected that cats from multicat households will have a
higher prevalence of B. henselae infection, as they are exposed
to the same environment and the same vectors that may trans-
mit the organism (3). However, crowding of cats did not play a
role in the present study. It is also noteworthy that stray cats
tested in animal shelters did not have an increased seropreva-
lence. Again, it is possible that more of these cats were infected
than was recognized serologically. These cats may be bactere-
mic with B. henselae yet may not have seroconverted. Yet the
main cause for this finding and the overall low prevalence in
this study may be a very low prevalence of flea infestation in
the cats in the tested geographic region.
In view of the prevalence of B. henselae infection among
cats, the question arises whether immunosuppressed people
should avoid all contact with cats. Considering the importance
of the animal bond for human well-being, separation from an
animal may not be wise. It may be advisable to screen pets
owned by immunocompromised people for B. henselae infec-
tion and to treat positive animals. However, the optimal anti-
biotic regimen for clearing bacteremia in infected cats has yet
to be found; so far, antibiotic treatment has not been shown to
consistently clear the infection from cats (7). When the bacte-
remia has subsided, cats appear to be immune to reinfection
with B. henselae (7, 22). It is at least as important to prevent
and treat flea infestation in cats, as fleas have been shown to be
a vector of the disease (5, 9).
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